Biotech Values

[DewDiligence]

NVS/MNTA had a 55% share of US Lovenox dollar sales in 2Q11. Here’s the arithmetic:

SNY’s 2Q11 US Lovenox sales were €160M (down from €222M in 1Q11): : http://en.sanofi.com/binaries/20110728_RESULTSQ2_en_tcm28-33120.pdf (page 4 and page 20). At the average exchange rate during 2Q11 of 1.43 dollars per euro, €160M translates into $229M.

Since NVS sold $284M of generic Lovenox in 2Q11 (#msg-65315981), 2Q11 total branded + generic US sales of Lovenox were $513M (up from $469M in 1Q11). 284/513 = 55%.